Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NeoLight
AddedFeb 15, 2024
UpdatedJun 18, 2026
NeoLight

NeoLight

NeoLight develops phototherapy beds and hypothermia devices to treat jaundice and low birth weight in newborns.

HQ
Scottsdale, AZ, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

NeoLight, founded with a mission to revolutionize neonatal care, focuses on developing advanced medical devices to treat jaundice and low birth weight in newborns. The company's core products include the Skylife™ Neonatal Phototherapy System, which offers superior phototherapy treatment for infant jaundice, and a device for hypothermia treatment. NeoLight aims to integrate cutting-edge technology with empathetic innovation to enhance neonatal health outcomes.

Notable individuals affiliated with NeoLight include experts in neonatal care and medical device innovation. The company has garnered significant investment from healthcare-focused venture capital firms. Key achievements include the successful deployment of Skylife™ in numerous neonatal intensive care units (NICUs), improving treatment efficacy and patient outcomes. NeoLight's impact is marked by its commitment to advancing neonatal care through innovative solutions, thereby setting new standards in the medical device industry.

NeoLight - Similar Companies

TheraB Medical logo

TheraB Medical

therabmedical.com

Photopharmics logo

Photopharmics

photopharmics.com

Photetica logo

Photetica

Light Line Medical logo

Light Line Medical

LumiThera logo

LumiThera

lumithera.com

Neatcap logo

Neatcap

neatcapmedical.com

Kilo Medical Solutions logo

Kilo Medical Solutions

PhotoThera logo

PhotoThera

Lightengale logo

Lightengale

Keraderm logo

Keraderm

JelikaLite logo

JelikaLite

jelikalite.com

Lumeda logo

Lumeda

lumedainc.com

Glucolight logo

Glucolight

Luma Therapeutics logo

Luma Therapeutics

Starlight Cardiovascular logo

Starlight Cardiovascular

NeoLight - Quick Facts

Who are NeoLight's competitors?

Companies similar to NeoLight include TheraB Medical, Photopharmics, Photetica and Light Line Medical.

When was NeoLight founded?

NeoLight was founded in 2014.

Where is NeoLight's headquarters located?

NeoLight's headquarters is located in Scottsdale, AZ, US.

When was NeoLight's last funding round?

NeoLight's most recent funding round was for $2.8M (USD) in January 2022.

How much has NeoLight raised to-date?

As of Jan 13, 2022, NeoLight has raised a total of $18.4M (USD).

How many employees does NeoLight have?

NeoLight has 125 employees as of Feb 5, 2024.

NeoLight - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
  • Phototherapy
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified